Interpace Biosciences
IDXG
#10519
Rank
NZ$64.62 M
Marketcap
NZ$10.95
Share price
-3.20%
Change (1 day)
534.99%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): NZ$6.99 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are NZ$36.14 Million. In 2025 the company made an earning of NZ$7.13 Million a decrease over its 2024 earnings that were of NZ$15.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$6.99 M-1.94%
2025 NZ$7.13 M-54.26%
2024 NZ$15.6 M303.23%
2023 NZ$3.86 M-144.63%
2022 -NZ$8.68 Million-60.98%
2021 -NZ$22.23 Million-52.04%
2020 -NZ$46.33 Million-2.68%
2019 -NZ$47.61 Million121.84%
2018 -NZ$21.46 Million-6.07%
2017 -NZ$22.85 Million96.31%
2016 -NZ$11.64 Million-86.7%
2015 -NZ$87.53 Million382.48%
2014 -NZ$18.15 Million134.35%
2013 -NZ$7.75 Million323.89%
2012 -NZ$1.83 Million-79.01%
2011 -NZ$8.71 Million29.08%
2010 -NZ$6.75 Million-82.57%
2009 -NZ$38.68 Million-39.28%
2008 -NZ$63.7 Million146.45%
2007 -NZ$25.85 Million-269.18%
2006 NZ$15.27 M-131.08%
2005 -NZ$49.15 Million-177.16%
2004 NZ$63.69 M78.33%
2003 NZ$35.71 M-142.02%
2002 -NZ$85 Million-469.63%
2001 NZ$22.99 M-68.92%
2000 NZ$73.98 M140.45%
1999 NZ$30.76 M
1997 NZ$4.34 M